{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:39:19Z","timestamp":1781671159349,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Human G protein-coupled receptors (GPCRs) respond to various ligands and stimuli. However, GPCRs rely on membrane for proper folding, making their biochemical properties difficult to study. By displaying GPCRs in viral envelopes, we fabricated a Virion Display (VirD) array containing 315 non-olfactory human GPCRs for functional characterization. Using this array, we found that 10 of 20 anti-GPCR mAbs were ultra-specific. We further demonstrated that those failed in the mAb assays could recognize their canonical ligands, suggesting proper folding. Next, using two peptide ligands on the VirD-GPCR array, we identified expected interactions and novel interactions. Finally, we screened the array with group B\n                    <jats:italic>Streptococcus<\/jats:italic>\n                    , a major cause of neonatal meningitis, and demonstrated that inhibition of a newly identified target, CysLTR1, reduced bacterial penetration both in vitro and in vivo. We believe that the VirD-GPCR array holds great potential for high-throughput screening for small molecule drugs, affinity reagents, and ligand deorphanization.\n                  <\/jats:p>","DOI":"10.1038\/s41467-019-09938-9","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T06:03:45Z","timestamp":1556604225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development and application of a high-content virion display human GPCR array"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4661-414X","authenticated-orcid":false,"given":"Guan-Da","family":"Syu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1197-659X","authenticated-orcid":false,"given":"Guangzhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atish","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Henson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien-Chun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devlina","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6513-9498","authenticated-orcid":false,"given":"Ignacio","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9750-7718","authenticated-orcid":false,"given":"Xinzhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2680-0503","authenticated-orcid":false,"given":"Shaopeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nongjian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant J.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8426-2889","authenticated-orcid":false,"given":"Heng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"9938_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schioth, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 16, 829\u2013842 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9938_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2017.11.033","volume":"172","author":"AS Hauser","year":"2018","unstructured":"Hauser, A. S. et al. Pharmacogenomics of GPCR drug targets. Cell 172, 41\u201354 e19 (2018).","journal-title":"Cell"},{"key":"9938_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/mol.117.111062","volume":"93","author":"K Sriram","year":"2018","unstructured":"Sriram, K. & Insel, P. A. G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs? Mol. Pharmacol. 93, 251\u2013258 (2018).","journal-title":"Mol. Pharmacol."},{"key":"9938_CR4","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cellsig.2005.05.020","volume":"17","author":"MT Duvernay","year":"2005","unstructured":"Duvernay, M. T., Filipeanu, C. M. & Wu, G. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal. 17, 1457\u20131465 (2005).","journal-title":"Cell Signal."},{"key":"9938_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/cmdc.200600134","volume":"1","author":"E Jacoby","year":"2006","unstructured":"Jacoby, E., Bouhelal, R., Gerspacher, M. & Seuwen, K. The 7 TM G-protein-coupled receptor target family. ChemMedChem 1, 761\u2013782 (2006).","journal-title":"ChemMedChem"},{"key":"9938_CR6","first-page":"66","volume":"6","author":"D Milic","year":"2015","unstructured":"Milic, D. & Veprintsev, D. B. Large-scale production and protein engineering of G protein-coupled receptors for structural studies. Front. Pharmacol. 6, 66 (2015).","journal-title":"Front. Pharmacol."},{"key":"9938_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1021\/ac0514164","volume":"78","author":"Y Fang","year":"2006","unstructured":"Fang, Y., Peng, J., Ferrie, A. M. & Burkhalter, R. S. Air-stable G protein-coupled receptor microarrays and ligand binding characteristics. Anal. Chem. 78, 149\u2013155 (2006).","journal-title":"Anal. Chem."},{"key":"9938_CR8","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1021\/ja017346+","volume":"124","author":"Y Fang","year":"2002","unstructured":"Fang, Y., Frutos, A. G. & Lahiri, J. Membrane protein microarrays. J. Am. Chem. Soc. 124, 2394\u20132395 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"9938_CR9","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1021\/ac401795y","volume":"85","author":"S Hu","year":"2013","unstructured":"Hu, S. et al. VirD: a virion display array for profiling functional membrane proteins. Anal. Chem. 85, 8046\u20138054 (2013).","journal-title":"Anal. Chem."},{"key":"9938_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jviromet.2006.03.014","volume":"135","author":"WW Gierasch","year":"2006","unstructured":"Gierasch, W. W. et al. Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J. Virol. Methods 135, 197\u2013206 (2006).","journal-title":"J. Virol. Methods"},{"key":"9938_CR11","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMoa1705848","volume":"377","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby, P. J. et al. A controlled trial of Erenumab for episodic migraine. New Engl. J. Med. 377, 2123\u20132132 (2017).","journal-title":"New Engl. J. Med."},{"key":"9938_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/ACI.S31614","volume":"11","author":"MG Weller","year":"2016","unstructured":"Weller, M. G. Quality issues of research antibodies. Anal. Chem. Insights 11, 21\u201327 (2016).","journal-title":"Anal. Chem. Insights"},{"key":"9938_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2144\/000113382","volume":"48","author":"J Bordeaux","year":"2010","unstructured":"Bordeaux, J. et al. Antibody validation. BioTechniques 48, 197\u2013209 (2010).","journal-title":"BioTechniques"},{"key":"9938_CR14","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1210\/me.2014-1230","volume":"28","author":"A Schonbrunn","year":"2014","unstructured":"Schonbrunn, A. Editorial: Antibody can get it right: confronting problems of antibody specificity and irreproducibility. Mol. Endocrinol. 28, 1403\u20131407 (2014).","journal-title":"Mol. Endocrinol."},{"key":"9938_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/527545a","volume":"527","author":"M Baker","year":"2015","unstructured":"Baker, M. Antibody anarchy: a call to order. Nature 527, 545\u2013551 (2015).","journal-title":"Nature"},{"key":"9938_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/518027a","volume":"518","author":"A Bradbury","year":"2015","unstructured":"Bradbury, A. & Pluckthun, A. Reproducibility: standardize antibodies used in research. Nature 518, 27\u201329 (2015).","journal-title":"Nature"},{"key":"9938_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1161\/HYPERTENSIONAHA.112.203679","volume":"61","author":"M Herrera","year":"2013","unstructured":"Herrera, M., Sparks, M. A., Alfonso-Pecchio, A. R., Harrison-Bernard, L. M. & Coffman, T. M. Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein. Hypertension 61, 253\u2013258 (2013).","journal-title":"Hypertension"},{"key":"9938_CR18","unstructured":"Venkataraman, A. et al. A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors. Nat. Methods 15, 330\u2013338 (2018)."},{"key":"9938_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1124\/mol.64.1.104","volume":"64","author":"F Marteau","year":"2003","unstructured":"Marteau, F. et al. Pharmacological characterization of the human P2Y13 receptor. Mol. Pharmacol. 64, 104\u2013112 (2003).","journal-title":"Mol. Pharmacol."},{"key":"9938_CR20","first-page":"136","volume":"286","author":"S Zhang","year":"1998","unstructured":"Zhang, S. et al. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family. J. Pharmacol. Exp. Ther. 286, 136\u2013141 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"9938_CR21","doi-asserted-by":"publisher","first-page":"20331","DOI":"10.1074\/jbc.271.34.20331","volume":"271","author":"G Liapakis","year":"1996","unstructured":"Liapakis, G. et al. Identification of ligand binding determinants in the somatostatin receptor subtypes 1 and 2. J. Biol. Chem. 271, 20331\u201320339 (1996).","journal-title":"J. Biol. Chem."},{"key":"9938_CR22","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/anie.201411040","volume":"54","author":"Y Fang","year":"2015","unstructured":"Fang, Y., Chen, S., Wang, W., Shan, X. & Tao, N. Real-time monitoring of phosphorylation kinetics with self-assembled nano-oscillators. Angew. Chem. Int. Ed. Engl. 54, 2538\u20132542 (2015).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"9938_CR23","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1021\/nl501805e","volume":"14","author":"X Shan","year":"2014","unstructured":"Shan, X. et al. Detection of charges and molecules with self-assembled nano-oscillators. Nano Lett. 14, 4151\u20134157 (2014).","journal-title":"Nano Lett."},{"key":"9938_CR24","doi-asserted-by":"publisher","first-page":"11495","DOI":"10.1021\/jacs.8b07461","volume":"140","author":"G Ma","year":"2018","unstructured":"Ma, G. et al. Measuring ligand binding kinetics to membrane proteins using virion nano-oscillators. J. Am. Chem. Soc. 140, 11495\u201311501 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"9938_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.cell.2010.11.035","volume":"143","author":"M Coureuil","year":"2010","unstructured":"Coureuil, M. et al. Meningococcus hijacks a beta2-adrenoceptor\/beta-Arrestin pathway to cross brain microvasculature endothelium. Cell 143, 1149\u20131160 (2010).","journal-title":"Cell"},{"key":"9938_CR26","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1128\/IAI.73.12.7827-7835.2005","volume":"73","author":"JN Radin","year":"2005","unstructured":"Radin, J. N. et al. beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect. Immun. 73, 7827\u20137835 (2005).","journal-title":"Infect. Immun."},{"key":"9938_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0188-4409(99)00074-0","volume":"30","author":"SM Wu","year":"1999","unstructured":"Wu, S. M. & Chan, W. Y. Male pseudohermaphroditism due to inactivating luteinizing hormone receptor mutations. Arch. Med. Res. 30, 495\u2013500 (1999).","journal-title":"Arch. Med. Res."},{"key":"9938_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuroscience.2014.07.058","volume":"277","author":"QF Lenz","year":"2014","unstructured":"Lenz, Q. F. et al. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction. Neuroscience 277, 859\u2013871 (2014).","journal-title":"Neuroscience"},{"key":"9938_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.virol.2014.02.007","volume":"454-455","author":"J Bertin","year":"2014","unstructured":"Bertin, J., Jalaguier, P., Barat, C., Roy, M. A. & Tremblay, M. J. Exposure of human astrocytes to leukotriene C4 promotes a CX3CL1\/fractalkine-mediated transmigration of HIV-1-infected CD4(+) T cells across an in vitro blood-brain barrier model. Virology 454-455, 128\u2013138 (2014).","journal-title":"Virology"},{"key":"9938_CR30","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1124\/mol.58.6.1601","volume":"58","author":"HP Nothacker","year":"2000","unstructured":"Nothacker, H. P. et al. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol. Pharmacol. 58, 1601\u20131608 (2000).","journal-title":"Mol. Pharmacol."},{"key":"9938_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11064-014-1478-9","volume":"40","author":"MA Saad","year":"2015","unstructured":"Saad, M. A., Abdelsalam, R. M., Kenawy, S. A. & Attia, A. S. Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats. Neurochem. Res. 40, 139\u2013150 (2015).","journal-title":"Neurochem. Res."},{"key":"9938_CR32","doi-asserted-by":"publisher","unstructured":"Zhu, L., Maruvada, R., Sapirstein, A., Peters-Golden, M., Kim, K. S. Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain. Cell. Microbiol. 19, https:\/\/doi.org\/10.1111\/cmi.12661 (2017).","DOI":"10.1111\/cmi.12661"},{"key":"9938_CR33","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/ijms14011589","volume":"14","author":"HH Shen","year":"2013","unstructured":"Shen, H. H., Lithgow, T. & Martin, L. Reconstitution of membrane proteins into model membranes: seeking better ways to retain protein activities. Int. J. Mol. Sci. 14, 1589\u20131607 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"9938_CR34","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1515\/BC.2009.091","volume":"390","author":"J Borch","year":"2009","unstructured":"Borch, J. & Hamann, T. The nanodisc: a novel tool for membrane protein studies. Biol. Chem. 390, 805\u2013814 (2009).","journal-title":"Biol. Chem."},{"key":"9938_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/09687688.2014.923588","volume":"31","author":"Y Hirozane","year":"2014","unstructured":"Hirozane, Y., Motoyaji, T., Maru, T., Okada, K. & Tarui, N. Generating thermostabilized agonist-bound GPR40\/FFAR1 using virus-like particles and a label-free binding assay. Mol. Membr. Biol. 31, 168\u2013175 (2014).","journal-title":"Mol. Membr. Biol."},{"key":"9938_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-481","volume":"8","author":"GA Karasneh","year":"2011","unstructured":"Karasneh, G. A. & Shukla, D. Herpes simplex virus infects most cell types in vitro: clues to its success. Virol. J. 8, 481 (2011).","journal-title":"Virol. J."},{"key":"9938_CR37","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1128\/jvi.62.8.2596-2604.1988","volume":"62","author":"WH Cai","year":"1988","unstructured":"Cai, W. H., Gu, B. & Person, S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62, 2596\u20132604 (1988).","journal-title":"J. Virol."},{"key":"9938_CR38","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1007\/s00216-010-3821-6","volume":"397","author":"TK Kim","year":"2010","unstructured":"Kim, T. K. & Eberwine, J. H. Mammalian cell transfection: the present and the future. Anal. Bioanal. Chem. 397, 3173\u20133178 (2010).","journal-title":"Anal. Bioanal. Chem."},{"key":"9938_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-10-9","volume":"10","author":"R Maurisse","year":"2010","unstructured":"Maurisse, R. et al. Comparative transfection of DNA into primary and transformed mammalian cells from different lineages. BMC Biotechnol. 10, 9 (2010).","journal-title":"BMC Biotechnol."},{"key":"9938_CR40","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1124\/mol.115.099440","volume":"88","author":"HF Vischer","year":"2015","unstructured":"Vischer, H. F., Castro, M. & Pin, J. P. G protein-coupled receptor multimers: a question still open despite the use of novel approaches. Mol. Pharmacol. 88, 561\u2013571 (2015).","journal-title":"Mol. Pharmacol."},{"key":"9938_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tips.2008.02.004","volume":"29","author":"VV Gurevich","year":"2008","unstructured":"Gurevich, V. V. & Gurevich, E. V. How and why do GPCRs dimerize? Trends Pharmacol. Sci. 29, 234\u2013240 (2008).","journal-title":"Trends Pharmacol. Sci."},{"key":"9938_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrd.2018.4","volume":"17","author":"A Mullard","year":"2018","unstructured":"Mullard, A. 2017 FDA drug approvals. Nat. Rev. Drug Discov. 17, 81\u201385 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9938_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrd.2017.14","volume":"16","author":"A Mullard","year":"2017","unstructured":"Mullard, A. 2016 FDA drug approvals. Nat. Rev. Drug Discov. 16, 73\u201376 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9938_CR44","doi-asserted-by":"publisher","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","volume":"284","author":"A Kapur","year":"2009","unstructured":"Kapur, A. et al. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J. Biol. Chem. 284, 29817\u201329827 (2009).","journal-title":"J. Biol. Chem."},{"key":"9938_CR45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1128\/jvi.67.3.1357-1364.1993","volume":"67","author":"P Desai","year":"1993","unstructured":"Desai, P., DeLuca, N. A., Glorioso, J. C. & Person, S. Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA. J. Virol. 67, 1357\u20131364 (1993).","journal-title":"J. Virol."},{"key":"9938_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/viro.1998.9230","volume":"247","author":"P Desai","year":"1998","unstructured":"Desai, P., DeLuca, N. A. & Person, S. Herpes simplex virus type 1 VP26 is not essential for replication in cell culture but influences production of infectious virus in the nervous system of infected mice. Virology 247, 115\u2013124 (1998).","journal-title":"Virology"},{"key":"9938_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0165-5728(97)00036-2","volume":"76","author":"MF Stins","year":"1997","unstructured":"Stins, M. F., Gilles, F. & Kim, K. S. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76, 81\u201390 (1997).","journal-title":"J. Neuroimmunol."},{"key":"9938_CR48","doi-asserted-by":"publisher","first-page":"O111 016253","DOI":"10.1074\/mcp.O111.016253","volume":"11","author":"JS Jeong","year":"2012","unstructured":"Jeong, J. S. et al. Rapid identification of monospecific monoclonal antibodies using a human proteome microarray. Mol. Cell. Proteomics 11, O111 016253 (2012).","journal-title":"Mol. Cell. Proteomics"},{"key":"9938_CR49","doi-asserted-by":"publisher","first-page":"E7245","DOI":"10.1073\/pnas.1704155114","volume":"114","author":"S Zhao","year":"2017","unstructured":"Zhao, S. et al. Kinetic and high-throughput profiling of epigenetic interactions by 3D-carbene chip-based surface plasmon resonance imaging technology. Proc. Natl. Acad. Sci. USA 114, E7245\u2013E7254 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9938_CR50","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1021\/ac504110t","volume":"87","author":"Z Cheng","year":"2015","unstructured":"Cheng, Z. et al. Plain silver surface plasmon resonance for microarray application. Anal. Chem. 87, 1466\u20131469 (2015).","journal-title":"Anal. Chem."},{"key":"9938_CR51","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1128\/IAI.05506-11","volume":"79","author":"R Maruvada","year":"2011","unstructured":"Maruvada, R., Zhu, L., Pearce, D., Sapirstein, A. & Kim, K. S. Host cytosolic phospholipase A(2)alpha contributes to group B Streptococcus penetration of the blood-brain barrier. Infect. Immun. 79, 4088\u20134093 (2011).","journal-title":"Infect. Immun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09938-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09938-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09938-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T18:06:15Z","timestamp":1671213975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09938-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9938"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09938-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/377754","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"7 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.Z., D.E. and I.P. are cofounders and shareholders of CDI Laboratories Inc. P.R. is an employee of CDI Laboratories Inc. H.Z., G.-D.S. and P.J.D. are consultants to CDI Laboratories Inc.\u00a0The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1997"}}